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I. Introduction
Prostate cancer is the leading cause of cancer morbidity and the second leading cause of cancer mortality among U.S. men, and is projected to account for an estimated 232,090 new cases and 30,350 deaths in the year 2005.The significant changes in incidence and mortality that occurred since 1988 (significant rise between 1988-92, decreased between 1992-95, and increase between 1995-2004 in men <65 years of age, have been attributed to increased awareness of the disease and efforts at early diagnosis with the Prostate-Specific Antigen (PSA). African American men have the highest incidence and mortality rates in the world and continue to experience significantly higher incidence and twice as high death rates as whites in the U.S. The disparity in morbidity and mortality between African American men in the U.S. has not been adequately studied or explained, although it is generally believed that a number of factors are responsible, including stage at diagnosis and accessibility to health care (American Cancer Society Facts and Figures, 2005) .
There is a great deal of controversy surrounding the interpretation of existing epidemiological and clinical evidence. Expert recommendations regarding the age, frequency and the necessity for the use of the Prostate Specific Antigen (PSA) and the Digital Rectal Examination (DRE) for mass screening in the general population as a public health policy remain conflicting and controversial. Results from large scale randomized controlled trials conducted by the National Cancer Institute and the European Union, necessary to document the benefits of screening through reduction in mortality, will be available in few years. Meanwhile, a number of case-control studies, including the present study, are underway to determine if screening with the PSA and DRE reduce mortality from prostate cancer.
II. Body
Objectives/Hypothesis: The objective of this study is to provide much needed data on the efficacy of screening for prostate cancer using observational case-control methodology while awaiting the results of randomized controlled trials and to explain the black white disparity in mortality from prostate cancer. The hypothesis to be tested is that the frequency of screening tests (DRE and PSA) should be higher in the general population than in the group of men who die from prostate cancer. Hospital, physician and laboratory records will be reviewed to assess the frequency of DRE and PSA tests in cases and controls for a period of 12 to 14 years prior to the date of death of the case and to include the exposure period prior to the reference date of diagnosis of the case. The odds ratio with 95% C.I. will be used for overall comparisons and within subgroups defined by risk factors and adjusted for co-morbidity. Logistic regression will be used to generate summary odds ratios adjusted for co-variates.
III. Key Research Accomplishments
Key research accomplishments are based on progress made relative to each of the items listed under Task 1-5 in the Statement of Work that follows and submitted as part of the revised Proposal.
Statement of Work
Task 1. Personnel Recruitment/Arrangements a. Prepare paper work, position description and advertisement.
Completed for both Atlanta and Florida Sites.
b. Hire and train data abstractor(s) at Morehouse School of Medicine and the University of Florida.
The hiring of personnel was completed at Morehouse School of Medicine from the inception of the Project. Yassa Nadjakani, MD, MPH has been associated with the project since the beginning (10/1/2001) although funding was not available for a considerable period of time during the transfer of the Project from MSM to UF. He continues to the present to be the Project Coordinator for the Atlanta area. We have hired new personnel in Florida -William Mkanta, PhD and Nicole Scheys, BS. Dr. Mkanta is the coordinator of the project. He is involved in the day-to-day administration of the project. He is responsible for establishing and maintaining contacts with hospital administration at Shands at the University of Florida, Shands Jacksonville, and VA hospitals. He is also involved in data abstraction, data analysis and IRB issues related to the project. Miss Scheys is responsible in record keeping, chart reviews, and preparation of reports. She also assists in patient interview in the Kidney Project whose PI is Dr. Asal. This activity has been completed. See tables 1 and 2 below.
b. Determine the adequacy of sample size projected in the proposal.
The following Tables (1 and 2 ) summarize the prostate cancer mortality data obtained from the Georgia and Florida Departments of Health (Georgia Department of Human Resources/Georgia Cancer Registry). The number of deaths recorded between blacks and whites Shown in Tables 1 and 2 above for the years 1998-2001 in Atlanta and Florida sites exceed the needed sample of 170 black and 280 white patients project as a minimum sample that will attain adequate power. The sample will be randomly selected from the list of patients making the prostate cancer mortality figures in Tables 1 and 2 . Forms have been modified, pre-tested, finalized, used, and continue to be used in both Atlanta and Florida.
Telephone screening forms to select controls have been modified, approved by the Army IRB, and ready to be used to select controls.
b. IRB packages will include the final medical record review forms and protocol with sampling and data collection strategies and final sample size estimates.
Since receiving the tentative approval from the Army on April 1, 2005, final approval of the protocol and IRB Consent forms from each of the participating hospitals in Atlanta and North Central Florida.
Task 4. Access Hospital Lists/Select Controls: a. Identify list of hospitals where cases were diagnosed in Georgia and Florida
Completed for Atlanta, but in initial stages in Florida.
b. Finalize arrangements with Florida hospitals for in-site visit
Visits have been made to the VA hospital, Shands at University of Florida, and Shands Jacksonville. Efforts are underway to start matching death records to identify cases that were treated at these facilities.
c. Selection of Controls at each hospital in Georgia and Florida.
Following completion of chart review for cases in Georgia, efforts are now directed to the selection of controls. This is not yet applicable in Florida. Completion of chart reviews for cases at the Atlanta site.
V. Conclusions.
The study is progressing fine after completion of institutional requirements following the Principal Investigator relocation from Morehouse School of Medicine in Atlanta to the University of Florida in Gainesville, Florida on July 1, 2002. The process of transferring the proposal and funding from Morehouse to UF has been completed. The final Army IRB approval is completed and the project is underway at the university of Florida. Also, the project is run through a sub-contract at Morehouse School of Medicine. The current IRB is valid up to August 2006. We anticipate by this date the study sample selection process would be completed.
VI. References.
Not Applicable. • Provided assistance to customers through interpersonal skills
VII
• Performed fast and efficient on cash register, took orders, prepared and baked pretzels
• Assisted managers with all daily functions, occasionally filling in for a shift
VOLUNTEER WORK Community Rounds
October 2004-present Multidisciplinary, student-run organization providing health care and education to Gainesville's underserved communities
